tiprankstipranks
Trending News
More News >
uniQure Aligns with FDA for AMT-130 BLA Approval
PremiumCompany AnnouncementsuniQure Aligns with FDA for AMT-130 BLA Approval
9d ago
uniQure provides regulatory update on AMT-130 for Huntington’s Disease
Premium
The Fly
uniQure provides regulatory update on AMT-130 for Huntington’s Disease
9d ago
Buy Recommendation for uniQure Driven by Promising AMT-260 Trial Results and Innovative LinQURE Technology
Premium
Ratings
Buy Recommendation for uniQure Driven by Promising AMT-260 Trial Results and Innovative LinQURE Technology
12d ago
uniQure’s Clinical and Regulatory Progress Drives Buy Rating Amid Market Overreaction
PremiumRatingsuniQure’s Clinical and Regulatory Progress Drives Buy Rating Amid Market Overreaction
28d ago
Optimistic Buy Rating on uniQure Amidst Progress in Huntington’s Disease Program and AMT-130 Developments
Premium
Ratings
Optimistic Buy Rating on uniQure Amidst Progress in Huntington’s Disease Program and AMT-130 Developments
29d ago
uniQure N.V. Earnings Call: Progress Amid Challenges
Premium
Company Announcements
uniQure N.V. Earnings Call: Progress Amid Challenges
29d ago
uniQure reports Q1 EPS (82c), consensus (93c)
PremiumThe FlyuniQure reports Q1 EPS (82c), consensus (93c)
1M ago
uniQure expects cash to fund operations into 2H of 2027
Premium
The Fly
uniQure expects cash to fund operations into 2H of 2027
1M ago
uniQure recent selloff overdone, says H.C. Wainwright
Premium
The Fly
uniQure recent selloff overdone, says H.C. Wainwright
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100